Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 190

1.

Recent clinical trials.

Gradman AH, Basile JN.

J Am Soc Hypertens. 2014 Oct;8(10):770-4; quiz 775-6. doi: 10.1016/j.jash.2014.08.006. Epub 2014 Aug 15. No abstract available.

PMID:
25418501
2.

Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).

Fatemi O, Yuriditsky E, Tsioufis C, Tsachris D, Morgan T, Basile J, Bigger T, Cushman W, Goff D, Soliman EZ, Thomas A, Papademetriou V.

Am J Cardiol. 2014 Oct 15;114(8):1217-22. doi: 10.1016/j.amjcard.2014.07.045. Epub 2014 Jul 30.

PMID:
25159234
3.

Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT.

Piller LB, Simpson LM, Baraniuk S, Habib GB, Rahman M, Basile JN, Dart RA, Ellsworth AJ, Fendley H, Probstfield JL, Whelton PK, Davis BR; ALLHAT Collaborative Research Group.

J Gen Intern Med. 2014 Nov;29(11):1475-83. doi: 10.1007/s11606-014-2947-1.

PMID:
25002161
4.

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.

Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M; NAC-MD-01 Study Investigators.

Lancet. 2014 May 31;383(9932):1889-98. doi: 10.1016/S0140-6736(14)60614-0.

PMID:
24881993
5.

Renal sympathetic denervation for blood pressure control: a review of the current evidence and ongoing studies.

Todoran TM, Basile JN, Zile MR.

J Clin Hypertens (Greenwich). 2014 May;16(5):331-41. doi: 10.1111/jch.12285. Epub 2014 Mar 21. Review.

PMID:
24655555
6.

Analysis of recent papers in hypertension treatment of hypertension in the setting of acute intracerebral hemorrhage: still no clear answer on the best BP level to intervene or what BP goal to achieve.

Basile JN, Bloch MJ.

J Clin Hypertens (Greenwich). 2014 Jan;16(1):1-3. doi: 10.1111/jch.12233. Epub 2013 Dec 11. No abstract available.

PMID:
24325638
7.

Review of recent literature in hypertension: updated clinical practice guidelines for chronic kidney disease now include albuminuria in the classification system.

Bloch MJ, Basile JN.

J Clin Hypertens (Greenwich). 2013 Dec;15(12):865-7. doi: 10.1111/jch.12209. Epub 2013 Sep 30. Review. No abstract available.

PMID:
24119153
8.

Analysis of recent papers in hypertension. Initial combination therapy provides more prompt blood pressure control and reduces cardiovascular events but remains underutilized.

Basile JN, Bloch MJ.

J Clin Hypertens (Greenwich). 2013 Aug;15(8):523-5. doi: 10.1111/jch.12124. Epub 2013 May 10. No abstract available.

PMID:
23889711
9.

Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT.

Rahman M, Baimbridge C, Davis BR, Barzilay JI, Basile JN, Henriquez MA, Huml A, Kopyt N, Louis GT, Pressel SL, Rosendorff C, Sastrasinh S, Stanford C; ALLHAT Collaborative Research Group.

Clin Nephrol. 2013 Oct;80(4):235-48. doi: 10.5414/CN107922.

PMID:
23816477
10.

Determining the relative antihypertensive potency and relative cardiovascular risk reduction associated with different thiazide and thiazide-type diuretics.

Basile JN, Bloch MJ.

J Clin Hypertens (Greenwich). 2013 Jun;15(6):359-61. doi: 10.1111/jch.12079. Epub 2013 Feb 27. No abstract available.

PMID:
23730981
11.

The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM).

Basile JN.

J Diabetes Complications. 2013 May-Jun;27(3):280-6. doi: 10.1016/j.jdiacomp.2012.12.004. Epub 2013 Feb 1. Review.

PMID:
23375850
12.

Analysis of recent papers in hypertension: Treatment of obstructive sleep apnea with continuous positive airway pressure appears to decrease the incidence of incident hypertension.

Bloch MJ, Basile JN.

J Clin Hypertens (Greenwich). 2013 Feb;15(2):85-7. doi: 10.1111/jch.12041. Epub 2012 Dec 14. No abstract available.

PMID:
23339724
13.
14.

Exposure to air pollution increases the incidence of hypertension and diabetes in black women living in Los Angeles.

Basile JN, Bloch MJ.

J Clin Hypertens (Greenwich). 2012 Nov;14(11):819-20. doi: 10.1111/jch.12000. Epub 2012 Aug 28. No abstract available.

PMID:
23126360
15.

Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinopril.

Weber MA, Basile J, Stapff M, Khan B, Zhou D.

J Clin Hypertens (Greenwich). 2012 Sep;14(9):588-92. doi: 10.1111/j.1751-7176.2012.00666.x. Epub 2012 Jun 4.

PMID:
22947356
16.

What should be the target blood pressure in patients with chronic kidney disease? Data from the Kidney Early Evaluation Program.

Bloch MJ, Basile J.

J Clin Hypertens (Greenwich). 2012 Jul;14(7):472-4. doi: 10.1111/j.1751-7176.2012.00636.x. Epub 2012 Apr 26. No abstract available.

PMID:
22747621
17.

NHANES data highlight the clinical characteristics of those with poorly controlled hypertension.

Basile JN, Bloch MJ.

J Clin Hypertens (Greenwich). 2012 Apr;14(4):267-8. doi: 10.1111/j.1751-7176.2012.00596.x. Epub 2012 Mar 6. No abstract available.

PMID:
22458751
18.

The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension: back to the drawing board.

Bloch MJ, Basile JN.

J Clin Hypertens (Greenwich). 2012 Mar;14(3):184-6. doi: 10.1111/j.1751-7176.2011.00584.x. Epub 2012 Jan 19. No abstract available.

PMID:
22372779
19.

2011 recommendations for the diagnosis and management of gout and hyperuricemia.

Hamburger M, Baraf HS, Adamson TC 3rd, Basile J, Bass L, Cole B, Doghramji PP, Guadagnoli GA, Hamburger F, Harford R, Lieberman JA 3rd, Mandel DR, Mandelbrot DA, McClain BP, Mizuno E, Morton AH, Mount DB, Pope RS, Rosenthal KG, Setoodeh K, Skosey JL, Edwards NL.

Phys Sportsmed. 2011 Nov;39(4):98-123. doi: 10.3810/psm.2011.11.1946. Review.

PMID:
22293773
20.

Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Cushman WC, Davis BR, Pressel SL, Cutler JA, Einhorn PT, Ford CE, Oparil S, Probstfield JL, Whelton PK, Wright JT Jr, Alderman MH, Basile JN, Black HR, Grimm RH Jr, Hamilton BP, Haywood LJ, Ong ST, Piller LB, Simpson LM, Stanford C, Weiss RJ; ALLHAT Collaborative Research Group.

J Clin Hypertens (Greenwich). 2012 Jan;14(1):20-31. doi: 10.1111/j.1751-7176.2011.00568.x. Epub 2011 Dec 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk